[Idiopatic pulmonary fibrosis: A new paradigm].  Idiopathic pulmonary fibrosis
((IPF) is the most common disease from a group of interstitial lung diseases, which occurs mainly in middle-aged and elderly people.
Over the past decade, there have been considerable changes in approaches to diagnosing and treating IPF.  The paper presents an update on the epidemiology of IPF, the results of new studies of its pathogenesis, and main approaches to diagnosing the disease.
In addition, there is new evidence on therapy for IPF.
